What you'll find on this page
- How we design Cochlear™ Nucleus® Implants.
- The Cochlear Nucleus Implant portfolio.
- The link between electrode design and hearing performance.
Cochlear's implant design philosophy
- Designed to support a lifetime of hearing performance.*
- Electrodes designed to fit the natural shape of the inner ear.1
- Support advances in sound processor technology.
World's thinnest cochlear implants
The Nucleus® Profile™ and Profile Plus Series Implants are the thinnest in the world.**
Designed to fit the natural shape of your inner ear, sitting closer to the hearing nerve for better hearing outcomes.2-4
Both Profile Plus and Profile Series Implants also have a high impact resistance — up to 2.5 joules — which meets the European standards for impact testing.
Industry-leading design for hearing performance
The anatomy of the cochlea varies from person to person. That's why we offer a range of electrode shapes and lengths. Your surgeon will decide which one is best for you.
Unique features of Cochlear's electrodes and implants include:
22 active contacts for precise frequency coverage.
The world's thinnest full-length electrode.5
Electrodes which sit closer to the hearing nerve for better hearing performance.2-4
Best long-term implant reliability record in the industry.**6
Please seek advice from your health professional about treatments for hearing loss. Outcomes may vary, and your health professional will advise you about the factors which could affect your outcome. Always follow the directions for use. Not all products are available in all countries. Please contact your local Cochlear representative for product information.
In Australia, Cochlear™ Nucleus® implant systems are intended for the treatment of moderately severe to profound hearing loss.
In Australia, Baha® bone conduction implant systems are intended for the treatment of moderate to profound hearing loss.
In Australia, the Cochlear™ Osia® System is indicated for patients with conductive, mixed hearing loss and single-sided sensorineural deafness (SSD) aged 10 years and above with up to 55 decibels sensorineural hearing loss. Patients should have sufficient bone quality and quantity to support successful implant placement. Surgery is required to use this product. Any surgical procedure carries risk.
For Cochlear™ Nucleus®, Osia® and Baha® systems: This product is not available for purchase by the general public. For information on funding and reimbursement please contact your health care professional.
Any testimonial featured on this website is intended for an Australian audience only.
* “A lifetime of hearing performance” and similar phrases should not be understood as claims relating to the expected life, reliability, quality or performance of Cochlear’s products.
** Based on implant generations released within a comparable period with 5+ years of CSP data.
- Shaul C, Dragovic AS, Stringer AK, O’Leary SJ, Briggs RJ. Scalar localisation of peri-modiolar electrodes and speech perception outcomes. J Laryngol Otol. 2018;132:1000–6.
- Ramos, Shaul and Holden: Shaul C, Dragovic AS, Stringer AK, O’Leary SJ, Briggs RJ. Scalar localisation of peri-modiolar electrodes and speech perception outcomes. J Laryngol Otol. 2018;132:1000–6.
- Holden LK, Finley CC, Firszt JB, Holden TA, Brenner C, Potts LG, et al. Factors affecting open-set word recognition in adults with cochlear implants. Ear Hear 2013; 34: 342-60.
- Ramos de Miguel A, Argudo AA, Borkoski Barreiro SA, Falcon Gonzalez JC, Ramos Macias A. Imaging evaluation of electrode placement and effect on electrode discrimination on different cochlear implant electrode arrays. Eur Arch Otorhinolaryngol. 2018 Jun;275(6):1385-1394.
- Cochlear Limited. D1655106. Competitive Comparison of Implant Intracochlear Electrode Thickness. 2019, October.
- Cochlear Limited. D2073229 Cochlear Reliability Report Volume 21, December 2022.